Reply
- PMID: 36538718
- DOI: 10.1097/DCR.0000000000002681
Reply
References
-
- Kosaraju RS, Wong DJ, Roth EM, et al. Dose-intensified infliximab rescue therapy for severe ulcerative colitis does not reduce short-term colectomy rates or increase postoperative complications. Dis Colon Rectum. 2022;65:1232–1240.
-
- Gupta V, Mohsen W, Chapman TP, Satsangi J. Predicting outcome in acute severe colitis—controversies in clinical practice in 2021. J Crohns Colitis. 2021;15:1211–1221.
-
- Afonso J, Lopes S, Gonçalves R, et al.; Portuguese IBD Study Group (GEDII). Proactive therapeutic drug monitoring of infliximab: a comparative study of a new point-of-care quantitative test with two established ELISA assays. Aliment Pharmacol Ther. 2016;44:684–692.
-
- Sarvestani SK, Signs S, Hu B, et al. Induced organoids derived from patients with ulcerative colitis recapitulate colitic reactivity. Nat Commun. 2021;12:262.
LinkOut - more resources
Full Text Sources